首页> 美国卫生研究院文献>Bioinformatics >Genome Fusion Detection: a novel method to detect fusion genes from SNP-array data
【2h】

Genome Fusion Detection: a novel method to detect fusion genes from SNP-array data

机译:基因组融合检测:从SNP阵列数据检测融合基因的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Motivation: Fusion genes result from genomic rearrangements, such as deletions, amplifications and translocations. Such rearrangements can also frequently be observed in cancer and have been postulated as driving event in cancer development. to detect them, one needs to analyze the transition region of two segments with different copy number, the location where fusions are known to occur. Finding fusion genes is essential to understanding cancer development and may lead to new therapeutic approaches.>Results: Here we present a novel method, the Genomic Fusion Detection algorithm, to predict fusion genes on a genomic level based on SNP-array data. This algorithm detects genes at the transition region of segments with copy number variation. With the application of defined constraints, certain properties of the detected genes are evaluated to predict whether they may be fused. We evaluated our prediction by calculating the observed frequency of known fusions in both primary cancers and cell lines. We tested a set of cell lines positive for the BCR-ABL1 fusion and prostate cancers positive for the TMPRSS2-ERG fusion. We could detect the fusions in all positive cell lines, but not in the negative controls.>Availability: The algorithm is available from the supplement.>Contact: >Supplementary information: are available at Bioinformatics online.
机译:>动机:融合基因来自基因组重排,例如缺失,扩增和易位。这种重排也经常在癌症中观察到,并被认为是癌症发展的驱动事件。为了检测它们,需要分析具有不同拷贝数的两个片段的过渡区域,即已知发生融合的位置。寻找融合基因对于理解癌症的发展至关重要,并且可能会导致新的治疗方法。>结果:在这里,我们提出一种新的方法,即基因组融合检测算法,可以基于SNP在基因组水平上预测融合基因数组数据。该算法检测具有拷贝数变化的片段过渡区域的基因。通过定义的约束条件,可以对检测到的基因的某些属性进行评估,以预测它们是否可以融合。我们通过计算在原发癌和细胞系中已知融合的观察频率来评估我们的预测。我们测试了一组对BCR-ABL1融合呈阳性的细胞系和对TMPRSS2-ERG融合呈阳性的前列腺癌。我们可以在所有阳性细胞系中检测到融合,但不能在阴性对照中检测到。>可用性:该算法可从补充中获得。>联系方式: >补充信息: 可从生物信息学在线获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号